Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
EntMedPall
2 other identifiers
interventional
200
1 country
1
Brief Summary
The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2024
CompletedFirst Submitted
Initial submission to the registry
June 27, 2024
CompletedFirst Posted
Study publicly available on registry
October 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJune 13, 2025
October 1, 2024
1 year
June 27, 2024
June 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
(I) Drug-related problems
(I) Number of drug-related problems at the time of discharge according to PCNE (comparison of prospective, actually proposed changes vs. hypothetical number and type of problems at the time of discharge in the retrospective comparison cohort)
12 months
(II) Drug-related problems
(II) Type of drug-related problems at the time of discharge according to PCNE (comparison of prospective, actually proposed changes vs. hypothetical number and type of problems at the time of discharge in the retrospective comparison cohort)
12 months
Secondary Outcomes (15)
Number of contacts
12 months
Number of readmissions / visits
12 months
Symptom burden
12 months
(I) Medication changes
12 months
Adoption rate
12 months
- +10 more secondary outcomes
Study Arms (2)
Prospective patients
EXPERIMENTALCurrent palliative care patients who are discharged from the University Hospital to outpatient palliative care.
Retrospective patients
NO INTERVENTIONFormer palliative care patients who were discharged from the university hospital to outpatient palliative care.
Interventions
These patients will receive structured pharmaceutical discharge management from inpatient to outpatient care.
Eligibility Criteria
You may qualify if:
- All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.):
- advanced, malignant tumour disease
- advanced, chronic obstructive pulmonary disease
- Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form
You may not qualify if:
- Impossibility of understanding the information and declaration of consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Muensterlead
- University Hospital Munichcollaborator
Study Sites (1)
University Hospital Muenster
Münster, North Rhine-Westphalia, 48149, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Christoph Klaas, Dr. rer. nat.
Pharmacy of the University Hospital Muenster
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2024
First Posted
October 18, 2024
Study Start
June 20, 2024
Primary Completion
June 30, 2025
Study Completion
December 31, 2025
Last Updated
June 13, 2025
Record last verified: 2024-10